alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
I 

113TH CONGRESS 

2D SESSION H. R. 5748 

To extend the requirement that drug manufacturers that increase prices 

faster than inflation pay an additional rebate to State Medicaid programs 

to include manufacturers of generic drugs. 

IN THE HOUSE OF REPRESENTATIVES 

NOVEMBER 20, 2014 

Mr. CUMMINGS introduced the following bill; which was referred to the 

Committee on Energy and Commerce 

A BILL 

To extend the requirement that drug manufacturers that 

increase prices faster than inflation pay an additional 

rebate to State Medicaid programs to include manufacturers of generic drugs. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘The Medicaid Generic 

5 Drug Price Fairness Act of 2014’’. 

mstockstill on DSK4VPTVN1PROD with BILLS

2 

•HR 5748 IH

1 SEC. 2. APPLYING THE MEDICAID ADDITIONAL REBATE RE2 QUIREMENT TO MANUFACTURERS OF GE3 NERIC DRUGS. 

4 (a) IN GENERAL.—Section 1927(c)(3)(A) of the So5 cial Security Act (42 U.S.C. 1396r–8(c)(3)(A)) is amend6 ed— 

7 (1) in clause (ii), by striking the period and in8 serting ‘‘,’’; and 

9 (2) by adding at the end the following flush 

10 text: ‘‘and shall be increased by an amount deter11 mined in the same manner as the increase in the 

12 amount of a rebate for a single source drug or an 

13 innovator multiple source drug is determined under 

14 paragraph (2).’’. 

15 (b) EFFECTIVE DATE.—The amendments made by 

16 this section shall apply to rebate periods beginning on or 

17 after the date of enactment of this Act. 

Æ 

mstockstill on DSK4VPTVN1PROD with BILLS
a.
    
    designed such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this report is being
prepared;b.
    
    designed such internal control over financial reporting, or caused such internal control
over financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting
principles;c.
    
    evaluated the effectiveness of the registrants disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the disclosure controls
and procedures, as of the end of the period covered by this report based on such evaluation;
andd.
    
    disclosed in this report any change in the registrants internal control over financial
reporting that occurred during the registrants most recent fiscal quarter (the registrants
fourth fiscal quarter in the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the registrants internal control over financial
reporting; and
  a.
    
    all significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely affect
the registrants ability to record, process, summarize and report financial information; andb.
    
    any fraud, whether or not material, that involves management or other employees who have
a significant role in the registrants internal control over financial reporting.
 Date: July 30, 2010
    By:
    /s/ Lewis W. Dickey, Jr.Lewis W. Dickey, Jr.Chairman, President and Chief Executive Officer
#### STATE v. JAMES BRUMFIELD, Alias ERNEST BRUMFIELD.

(Filed 23 April, 1930.)

Criminal Law L a — Appeal in capital cases will be dismissed for failure to prosecute according to Rules of Court, no errors appealing of record.

Whether the Supreme Court acquires jurisdiction of an appeal in *forma pauperis*from a conviction of a capital felony when the affidavit for leave to appeal fails to state, as required by C. S., 4651, that the “application is in good faith,” *qucere?*and where the appeal has not been prosecuted as required by the Rules of Court the appeal will be dismissed upon motion of the Attorney-General after an examination of the record for errors appearing upon its face.

MotioN by State to dismiss appeal.

*Attorney-General Brummitt and Assistant Attorney-General Nash for the State.*

Stacy, C. J.

At tbe October Criminal Term, 1929, of Union Superior Court, tbe defendant herein, James Brumfield, was tried upon an indictment charging him with a capital felony, to wit, burglary in the first degree, wbicb resulted in a conviction and sentence of death. From tbe verdict thus rendered and judgment entered thereon, tbe defendant gave notice of appeal to tbe Supreme Court, but this has not been prosecuted as required by tbe rules. Indeed, as tbe attempted appeal is in *forma pauperis,*and tbe affidavit for leave to appeal without giving security for costs fails to state, as required by C. S., 4651, tbat “tbe application is in good faith,” it may be doubted as to whether we have any jurisdiction to bear tbe matter. *S. v. Martin,*172 N. C., 977, 90 S. E., 502. Nevertheless, as tbe life of tbe prisoner is involved, we have examined tbe case and find no error on tbe face of tbe record.

Tbe motion of tbe State must be allowed.

Appeal dismissed.
<PAGE>
                                                                    Exhibit 99.2



                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         In connection with the Quarterly Report of Washington Banking Company
(the "Company") on Form 10-Q for the period ending June 30, 2002, as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I,
Phyllis A. Hawkins , Chief Financial Officer of the Company, certify, pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

(1)      The Report fully complies with the requirements of Section 13(a) or
         15(d) of the Securities Exchange Act of 1934; and

(2)      The information contained in the Report fairly presents, in all
         material respects, the financial condition and result of operations of
         the Company.

This certification is being furnished solely to comply with the requirements of
18 U.S.C. Section 1350, and shall not be incorporated by reference into any of
the Company's filings under the Securities Act of 1933 or the Securities
Exchange Act of Securities Exchange Act of 1934, or otherwise be deemed to be
filed as part of the Report or under such Acts.



/s/ Phyllis A. Hawkins
----------------------------------------
Phyllis A. Hawkins
Chief Financial Officer


August 13, 2002
exv10w3






EXHIBIT
10.3



Confidential Materials omitted and filed separately with the Securities and Exchange Commission.
Asterisks denote omissions.




Schedule Number 3003078500 v. 1.0

For Professional Services Governed by the

Master Agreement for U.S. Availability Services

Between

SunGard Availability Services LP and ATHENAHEALTH




Dated March 31, 2007




Page 1 of 1



Schedule Reference Name: Business Continuity Program



Schedule Effective Date: July 1, 2009




SERVICES








The Services as described in the Statement of Work, Business Continuity Program (28124) dated 6/23/2009 (“SOW”)
is attached hereto and made a part hereof. The total value for the Services for this SOW is $*, which is due
and payable as follows:








	 	 	 	 	 	 
	 	Upon Schedule Effective Date

	 	 	$*	 
	 	One Month Following Schedule Effective Date

	 	 	$*	 
	 	At Project Completion

	 	 	$*	 
	 





	 	 	 
	CUSTOMER INFORMATION	 	 
	 
	BILL TO ADDRESS:

	 	311 ARSENAL STREET, WATERTOWN, MA 02472 US

DAVID ROBINSON
	NOTIFICATION ADDRESS:

	 	311 ARSENAL STREET, WATERTOWN, MA 02472 US

DAVID ROBINSON





This Schedule is not subject to auto renewal and will terminate at the end of the agreed term.



By the signatures of their duly authorized representatives below, SunGard and Customer, intending
to be legally bound, agree to all of the provisions of this Schedule and ratify the terms of the
Master Agreement.




	 	 	 	 	 	 	 
	SUNGARD AVAILABILITY SERVICES LP
	 	ATHENAHEALTH
	By:

	 	/s/ Christopher Coleman
	 	By:
	 	/s/ David E. Robinson
	 

	 	 
	 	 	 	 
	Print Name: Christopher Coleman

	 	Print Name: David E. Robinson
	Print Title: Vice President

	 	Print Title: COO
	Date Signed: 6/29/2009

	 	Date Signed: 6/23/2009
#### GEORGIA WHITE, Administratrix of M. L. WHITE, Deceased, v. JACK COULBOURN.

(Filed 27 September, 1939.)

Appeal by plaintiff from *Bone, J.,*at May Term, 1939, of Bertie.

Civil action for recovery of damages for alleged wrongful death resulting from injury received in a collision between a Ford automobile operated by intestate of plaintiff on U. S. Highway 17, between Windsor and Edenton, and a Chrysler automobile operated by the defendant.

On the trial below the parties through numerous witnesses presented evidence to the jury in support of their respective contentions. The jury answered in the negative the issue: “Was the plaintiff’s intestate wrongfully killed by the negligence of the defendant, as alleged in the complaint ?”

From judgment thereon, plaintiff appeals to the Supreme Court, and assigns error.

*Gillam & Spruill and J. H. Matthews for plaintiff, appellant.*

*J. A. Pritchett for defendant, appellee.*

Per Curiam.

In the light of the answer to the first issue, many of the exceptions presented on this appeal become immaterial. Careful consideration of all the exceptions fails to reveal reversible error. The case appears to have been fairly presented to the jury. In the judgment on the verdict, we find

No error.
733 A.2d 491

#### STATE OF NEW JERSEY, PLAINTIFF-RESPONDENT, v. LORI FERRO, DEFENDANT-MOVANT.

March 16, 1999.

Leave to appeal is granted, and the matter is summarily remanded to the Appellate Division for consideration of the appeal on the merits in the light of *State v. Anthony Caliguiri,*158 *N.J.*28, 726 A.2d 912 (1999); and it is further

ORDERED that the motion for a stay (M-748) is granted pending the disposition of the appeal in the Appellate Division.
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 98-6568

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

versus

ANDRE WILLIAMS, a/k/a Andre Curry, a/k/a Drey,

Defendant - Appellee.

Appeal from the United States District Court for the Northern

District of West Virginia, at Clarksburg. William M. Kidd, Senior

District Judge. (CR-93-48, CA-97-137)

Submitted: October 8, 1998 Decided: October 26, 1998

Before WIDENER, NIEMEYER, and MICHAEL, Circuit Judges.

Dismissed by unpublished per curiam opinion.

Andre Williams, Appellant Pro Se. William David Wilmoth, United

States Attorney, Wheeling, West Virginia; Thomas Oliver Mucklow,

Assistant United States Attorney, Martinsburg, West Virginia, for

Appellee.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2

PER CURIAM:

Andre Williams seeks to appeal the district court’s order denying his motion filed under 28 U.S.C.A. § 2255 (West 1994 & Supp.

1998). We have reviewed the record and the district court’s opinion

and find no reversible error. Accordingly, we deny a certificate of

appealability and dismiss the appeal on the reasoning of the

district court. United States v. Williams, Nos. CR-93-48; CA-97-137

(N.D.W. Va. Mar. 30, 1998). We dispense with oral argument because

the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional

process.

DISMISSED
Skip to main content

# Social Security

Search
Menu
Español
Sign in

## SSI Federal Payment Amounts
```
[Federal Register Volume 60, Number 235 (Thursday, December 7, 1995)]
[Sunshine Act Meetings]
[Page 62925]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-29954]

Commodity Futures Trading Commission

TIME AND DATE: 11:00 a.m., Friday, December 22, 1995.

PLACE: 1155 21st St., NW., Washington, DC 9th Floor Conference Room.

STATUS: Closed.

MATTERS TO BE CONSIDERED: Surveillance Matters.

CONTACT PERSON FOR MORE INFORMATION: Jean A. Webb, 202-418-5100.
Jean A Webb,

Secretary of the Commission.

[FR Doc. 95-29954 Filed 12-5-95; 1:35 pm]

BILLING CODE 6351-01-M
```
Exhibit 32.1
   (1)
    
    The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and(2)
    
    The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company as of the dates and for the
periods expressed in the Report.
 /s/ Lewis W. Dickey, Jr.Name:
    Lewis W. Dickey, Jr.Title:
    Chairman, President and Chief Executive Officer /s/ Joseph P. HannanName:
    Joseph P. HannanTitle:
    Senior Vice President, Treasurer and
Chief Financial Officer
[Federal Register Volume 60, Number 244 (Wednesday, December 20, 1995)]
[Notices]
[Page 65648]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-30864]



-----------------------------------------------------------------------

DEPARTMENT OF ENERGY
[Docket No. RP90-95-011]


Colorado Interstate Gas Company; Notice of Compliance Filing

December 14, 1995.
    Take notice that on December 11, 1995, Colorado Interstate Gas 
Company (CIG), tendered for filing a semiannual compliance filing 
consisting of work papers detailing accrued interest payments made by 
CIG to its affected customers related to the unused portion of 
transportation credits in the instant docket.
    CIG states that copies of the filing were served upon all of the 
parties to this proceeding and affected state commissions and affected 
parties.
    Any person desiring to protest said filing should file a protest 
with the Federal Energy Regulatory Commission, 888 First Street, N.E., 
Washington, D.C. 20426, in accordance with Section 385.211 of the 
Commission's Rules and Regulations. Pursuant to Section 154.210 of the 
Commission's regulations, all such protests must be filed not later 
than 12 days after the date of the filing noted above. Protests will be 
considered by the Commission in determining the appropriate action to 
be taken but will not serve to make protestants parties to the 
proceeding. Copies of this filing are on file with the Commission and 
are available for public inspection in the Public Reference Room.
Lois D. Cashell,
Secretary.
[FR Doc. 95-30864 Filed 12-19-95; 8:45 am]
BILLING CODE 6717-01-M
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Centers for Disease Control and Prevention

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting:

*Time and Date:*                         8:30 a.m.-6 p.m., June 23, 2010 (Closed).                    

*Place:*                         W Hotel—Buckhead, 3377 Peachtree Road, NE., Atlanta, GA 30326, (678) 500-3100.                    

*Status:*                         The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.                    

*Matters To Be Discussed:*                         The meeting will include the initial review, discussion, and evaluation of applications received in response to “Examining the Impact of Cognitive Impairment on Co-Occurring Chronic Conditions SIP 10-037 and Epidemiologic Follow-up Study of Newly Diagnosed Epilepsy SIP 10-039.”                    

*Contact Person for More Information:*                         Michelle Mathieson, Public Health Analyst, National Center for Chronic Disease and Health Promotion, Office of the Director, Extramural Research Program Office, CDC, 4770 Buford Highway, NE., Mailstop K-92, Atlanta, GA 30341, Telephone: (770) 488-3068, E-mail:                         *mth8@cdc.gov.*

                        The Director, Management Analysis and Services Office, has been delegated the authority to sign                         **Federal Register**                         notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.                    

Dated: May 28, 2010.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.

[FR Doc. 2010-13519 Filed 6-4-10; 8:45 am]

BILLING CODE 4163-18-P
Exhibit 32.1

Certification of Chief Executive Officer

Pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to

to Section 906 of the Sarbanes-Oxley Act of 2002

The undersigned, the Chief Executive Officer of SAVVIS, Inc. (the Company), hereby certifies that, to his knowledge on the date hereof:



|(a) | the quarterly report on Form 10-Q for the quarterly period ended September 30, 2009, filed on the date hereof with the Securities and Exchange Commission (the
Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934: and
|--- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|(b) | information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|--- | ------------------------------------------------------------------------------------------------------------------------------------------------



|                          |  |  |  |                         |  |                   
|------------------------- |  |  |  | ----------------------- |  | ------------------
|Date:    November 5, 2009 |  |  |  | By:                     |  | /s/ Philip J. Koen
|                          |  |  |  | Philip J. Koen         
|                          |  |  |  | Chief Executive Officer



37
EXHIBIT 32



CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly  Report of Meditecnic, Inc. (the "Company") on Form  10-QSB for the quarter  ended September 30, 2005, as filed with the Securities and Exchange  Commission on the date hereof  (the "Report"),  I, Bernard Arbalet, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and



(2) The  information  contained in the Report fairly  presents,  in all material  respects, the financial condition and results of operations of the Company.



/s/ Bernard Arbalet

By: Bernard Arbalet

Chief Executive  Officer

November 6, 2008
Exhibit 35.5

SERVICER COMPLIANCE CERTIFICATE

PURSUANT TO ITEM 1123 OF REGULATION AB UNDER THE

SECURITIES EXCHANGE ACT OF 1934

|   | Re: | HSBC Automotive Trust (USA) 2007-1 |
|--------|-----|------------------------------------|

I, David Grimme, Chief Operating Officer of HSBC Electronic Data Processing (Philippines) Inc. (the “Company”), pursuant to Item 1123 of Regulation AB of the Securities and Exchange Commission and Section 4.10(a) of the Sale and Servicing Agreement, dated as of January 31, 2007 (the “Agreement”), among HSBC Automotive Trust (USA) 2007-1, as Issuer, HSBC Auto Receivables Corporation, as Seller, HSBC Finance Corporation, as Servicer, Deutsche Bank Trust Company Americas, as Indenture Trustee, and HSBC Bank USA, National Association, as Administrator, hereby certify that:

 

|   | 1. | A review of the activities of the Company from January 31, 2007 through December 31, 2007 and of its performance under the Agreement has been made under my supervision; and |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

 

|   | 2. | To the best of my knowledge, based on my review, the Company has fulfilled all of its obligations under the Agreement in all material respects throughout the reporting period referred to above except as set forth below: |
|--------|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

 

|   | NONE |
|--------|------|

 

IN WITNESS WHEREOF, I have signed this certificate on behalf of the Company this 3rd day of March 2008.

|   | . |
|--------|---|

 

HSBC Electronic Data Processing (Philippines) Inc.

 

By:  /s/ David Grimme

Name:  David Grimme

Title:  Chief Operating Officer